Ganglioglioma medical therapy: Difference between revisions

	Ganglioglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Ganglioglioma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ganglioglioma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ganglioglioma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onGanglioglioma medical therapy
CDC on Ganglioglioma medical therapy
Ganglioglioma medical therapy in the news
on Ganglioglioma medical therapy
Directions to Hospitals Treating Ganglioglioma
Risk calculators and risk factors for Ganglioglioma medical therapy

Revision as of 23:42, 27 August 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Seizures are typically resistant to anti-epileptic drugs.

@@ Line 4: / Line 4: @@
 ==Overview==
-[[Radiotherapy]] or [[chemotherapy]] is not the first-line treatment option for patients with gangliogliomas. [[Radiation therapy]] is usually reserved for patients when either incomplete [[resection]] is achievable or tumor recurrence occurs.<ref name=dd>Rx of ganglioglioma. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/ganglioglioma</ref>
 ==Medical therapy==